title: Signal peptide cleavage is essential for surface expression of a regulatory T cell surface protein, leucine rich repeat containing 32 (LRRC32).
abstract: BACKGROUND
  Elevated numbers of regulatory T cells (T(regs)) have been implicated in certain cancers. Depletion of T(regs) has been shown to increase anti-tumor immunity. T(regs) also play a critical role in the suppression of autoimmune responses. The study of T(regs) has been hampered by a lack of adequate surface markers. Leucine Rich Repeat Containing 32 (LRRC32), also known as Glycoprotein A Repetitions Predominant (GARP), has been postulated as a novel surface marker of activated T(regs). However, there is limited information regarding the processing of LRRC32 or the regulatory phenotype and functional activity of T(regs) expressing LRRC32.
  
  
  RESULTS
  Using naturally-occurring freshly isolated T(regs), we demonstrate that low levels of LRRC32 are present intracellularly prior to activation and that freshly isolated LRRC32+ T(regs) are distinct from LRRC32- T(regs) with respect to the expression of surface CD62L. Using LRRC32 transfectants of HEK cells, we demonstrate that the N-terminus of LRRC32 is cleaved prior to expression of the protein at the cell surface. Furthermore, we demonstrate using a construct containing a deleted putative signal peptide region that the presence of a signal peptide region is critical to cell surface expression of LRRC32. Finally, mixed lymphocyte assays demonstrate that LRRC32+ T(regs) are more potent suppressors than LRRC32- T(regs).
  
  
  CONCLUSIONS
  A cleaved signal peptide site in LRRC32 is necessary for surface localization of native LRRC32 following activation of naturally-occurring freshly-isolated regulatory T cells. LRRC32 expression appears to alter the surface expression of activation markers of T cells such as CD62L. LRRC32 surface expression may be useful as a marker that selects for more potent T(reg) populations. In summary, understanding the processing and expression of LRRC32 may provide insight into the mechanism of action of T(regs) and the refinement of immunotherapeutic strategies aimed at targeting these cells.
authors: Department of Dermatology, University Hospitals Case Medical Center and Case Western Reserve University, Cleveland, OH, 44106 USA. derek.chan@uhhospitals.org
authors: Derek V
authors: DV
authors: Chan
authors: Ally-Khan
authors: AK
authors: Somani
authors: Andrew B
authors: AB
authors: Young
authors: Jessica V
authors: JV
authors: Massari
authors: Jennifer
authors: J
authors: Ohtola
authors: Hideaki
authors: H
authors: Sugiyama
authors: Edina
authors: E
authors: Garaczi
authors: Denise
authors: D
authors: Babineau
authors: Kevin D
authors: KD
authors: Cooper
authors: Thomas S
authors: TS
authors: McCormick
references: Arch Biochem Biophys. 2005 Sep 15;441(2):107-11
references: 16126156
references: Cytogenet Cell Genet. 1997;79(1-2):125-31
references: 9533029
references: Nat Protoc. 2007;2(4):953-71
references: 17446895
references: Genomics. 1997 Feb 1;39(3):340-7
references: 9119371
references: J Immunol. 2010 Apr 15;184(8):4317-26
references: 20231690
references: J Immunol. 2017 Feb 1;198(3):981-985
references: 28115586
references: Int Immunol. 2008 Mar;20(3):307-15
references: 18184698
references: J Immunol. 1995 Aug 1;155(3):1151-64
references: 7636184
references: J Immunol. 1999 May 15;162(10):5813-20
references: 10229815
references: Immunol Lett. 2004 Aug 15;95(1):63-70
references: 15325799
references: Int J Dev Biol. 1996 Jun;40(3):545-55
references: 8840187
references: Nat Immunol. 2003 Apr;4(4):337-42
references: 12612581
references: Blood. 2009 May 21;113(21):5125-33
references: 19299332
references: J Immunol. 1999 Aug 1;163(3):1128-31
references: 10415006
references: Science. 1969 Nov 7;166(3906):753-5
references: 5823314
references: J Membr Biol. 1990 May;115(3):195-201
references: 2197415
references: Cell Growth Differ. 1994 Feb;5(2):213-9
references: 8180135
references: J Mol Biol. 2004 Jul 16;340(4):783-95
references: 15223320
references: Science. 2000 Oct 27;290(5492):816-9
references: 11052947
references: Nat Immunol. 2008 Mar;9(3):239-44
references: 18285775
references: Trends Immunol. 2005 Mar;26(3):136-40
references: 15745855
references: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15292-3
references: 14676329
references: Nat Immunol. 2003 Apr;4(4):330-6
references: 12612578
references: Nat Immunol. 2005 Apr;6(4):327-30
references: 15785757
references: Regul Pept. 2004 Dec 15;123(1-3):181-5
references: 15518910
references: Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13439-44
references: 19666573
references: J Immunol. 2000 Jan 1;164(1):240-7
references: 10605017
references: Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15059-64
references: 14608036
references: J Cell Mol Med. 2009 Sep;13(9B):3343-57
references: 19453521
references: Nat Cell Biol. 2004 Jan;6(1):38-44
references: 14688794
references: J Exp Med. 1994 Nov 1;180(5):1999-2004
references: 7964477
references: Science. 2006 Sep 29;313(5795):1972-5
references: 16931720
references: Mamm Genome. 1992;2(3):195-200
references: 1543912
references: Immunity. 2000 Apr;12(4):431-40
references: 10795741
references: Int J Cancer. 2007 Dec 1;121(11):2473-83
references: 17691114
references: Immunol Rev. 2005 Apr;204:184-94
references: 15790359
references: Nat Immunol. 2002 Feb;3(2):135-42
references: 11812990
references: Toxicol Appl Pharmacol. 1997 Sep;146(1):1-10
references: 9299591
references: J Cell Biol. 1982 Nov;95(2 Pt 1):463-9
references: 6292235
references: J Immunol. 2009 Jan 1;182(1):111-20
references: 19109141
references: J Immunol. 1988 Apr 1;140(7):2171-8
references: 2965180
references: Lupus. 2008 May;17(5):421-5
references: 18490420
references: Hum Immunol. 2009 May;70(5):294-9
references: 19236900
references: PLoS One. 2008 Jul 16;3(7):e2705
references: 18628982
references: Immunogenetics. 2005 Jan;56(10):710-21
references: 15578176
references: Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13445-50
references: 19651619
references: J Immunol. 2005 Jan 1;174(1):164-73
references: 15611238
references: J Exp Med. 2006 Jul 10;203(7):1701-11
references: 16818678
references: Eur J Immunol. 2009 Dec;39(12):3315-22
references: 19750484
references: Immunol Lett. 2004 Jun 15;94(1-2):115-22
references: 15234543
references: Nature. 2003 Dec 18;426(6968):895-9
references: 14685250
references: J Exp Med. 1997 Feb 3;185(3):393-403
references: 9053440
references: J Exp Med. 2001 Sep 3;194(5):629-44
references: 11535631
references: J Immunol. 1997 Aug 15;159(4):1686-94
references: 9257829
references: J Exp Med. 2000 Jul 17;192(2):303-10
references: 10899917
references: Am J Transplant. 2004 Jan;4(1):65-78
references: 14678036
references: J Exp Med. 2009 Feb 16;206(2):421-34
references: 19188497
references: Immunity. 2002 Feb;16(2):311-23
references: 11869690
references: J Cell Biol. 1982 Nov;95(2 Pt 1):470-7
references: 6292236